Location History:
- South Australia, AU (2018)
- College Park, AU (2007 - 2022)
Company Filing History:
5 out of 323 
5 out of 11 
3 out of 3 
Years Active: 2007-2025
Title: Leanne Michelle Dibbens: Innovator in Genetic Research
Introduction
Leanne Michelle Dibbens is a prominent inventor based in College Park, Australia. She has made significant contributions to the field of genetic research, particularly in understanding seizure and movement disorders. With a total of 8 patents, her work has paved the way for advancements in diagnostic and therapeutic methods.
Latest Patents
Dibbens' latest patents include groundbreaking inventions related to the proline rich transmembrane protein 2 (PRRT2) gene. Her work focuses on identifying mutations and variations in the PRRT2 gene that are associated with seizure and movement disorders. This invention provides methods for diagnosing and prognosing such disorders by detecting alterations in the PRRT2 gene. Additionally, she has developed an isolated nucleic acid molecule that produces a seizure and/or movement disorder phenotype. Another significant patent involves diagnostic and therapeutic methods for epilepsy and mental retardation limited to females (EFMR). This includes methods and kits for diagnosing illnesses related to protocadherin 19 (PCDH19) protein deficiency, as well as therapeutic treatments for PCDH19 deficiency.
Career Highlights
Throughout her career, Dibbens has worked with esteemed institutions such as the University of Melbourne and Central Adelaide Local Health Network Inc. Her research has significantly impacted the understanding of genetic disorders, leading to improved diagnostic and treatment options.
Collaborations
Dibbens has collaborated with notable professionals in her field, including Samuel Frank Berkovic and John Charles Mulley. These collaborations have further enhanced her research and contributions to genetic science.
Conclusion
Leanne Michelle Dibbens is a trailblazer in genetic research, with a focus on seizure and movement disorders. Her innovative patents and collaborations have made a lasting impact on the field, providing valuable insights and advancements in diagnosis and treatment.